|
The efficacy of Zafirlukast as a SARS-CoV-2 helicase inhibitor in adult patients with moderate COVID-19 Pneumonia (pilot randomized clinical trial) |
|
|
|
Titel: |
The efficacy of Zafirlukast as a SARS-CoV-2 helicase inhibitor in adult patients with moderate COVID-19 Pneumonia (pilot randomized clinical trial) |
Auteur: |
Ghobain, M.Al Rebh, F. Saad, A. Khan, A.H. Mehyar, N. Mashhour, A. Islam, I. Alobaida, Y. Alaskar, A.S. Boudjelal, M. Jeraisy, M.Al |
Verschenen in: |
Journal of infection and public health |
Paginering: |
Jaargang 15 () nr. 12 pagina's 1546-1550 |
Jaar: |
2022 |
Inhoud: |
|
Uitgever: |
The Author(s) |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|